Literature DB >> 15906108

Intracellular mapping of the distribution of metals derived from the antitumor metallocenes.

Jenny B Waern1, Hugh H Harris, Barry Lai, Zhonghou Cai, Margaret M Harding, Carolyn T Dillon.   

Abstract

The intracellular distribution of transition metals in V79 Chinese hamster lung cells treated with subtoxic doses of the organometallic anticancer complexes Cp(2)MCl(2), where Cp is eta (5) -cyclopentadienyl and M is Mo, Nb, Ti, or V, has been studied by synchrotron-based X-ray fluorescence (XRF). While significantly higher concentrations of Mo and Nb were found in treated cells compared with control cells, distinct differences in the cellular distribution of each metal were observed. Analysis of thin sections of cells was consistent with some localization of Mo in the nucleus. Studies with a noncytotoxic thiol derivative of molybdocene dichloride showed an uneven distribution of Mo in the cells. For comparison, the low levels of Ti and V in cells treated with the more toxic titanocene and vanadocene complexes, respectively, resulted in metal concentrations at the detection limit of XRF. The results agree with independent chemical studies that have concluded that the biological chemistry of each of the metallocene dihalides is unique.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15906108     DOI: 10.1007/s00775-005-0649-1

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  24 in total

Review 1.  Applications of synchrotron-based X-ray microprobes.

Authors:  P M Bertsch; D B Hunter
Journal:  Chem Rev       Date:  2001-06       Impact factor: 60.622

2.  [Molybdocene dichloride as an antitumor agent (author's transl)].

Authors:  P Köpf-Maier; M Leitner; R Voigtländer; H Köpf
Journal:  Z Naturforsch C Biosci       Date:  1979-12

3.  Titanium(IV) targets phosphoesters on nucleotides: implications for the mechanism of action of the anticancer drug titanocene dichloride.

Authors:  M Guo; Z Guo; P J Sadler
Journal:  J Biol Inorg Chem       Date:  2001-09       Impact factor: 3.358

4.  Different inhibition pattern of the nucleic acid metabolism after in vitro treatment with titanocene and vanadocene dichlorides.

Authors:  P Köpf-Maier; W Wagner; H Köpf
Journal:  Naturwissenschaften       Date:  1981-05

5.  Intracellular distribution of titanium after treatment with the antitumor agent titanocene dichloride: on electron energy loss spectroscopic study.

Authors:  P Köpf-Maier; D Krahl
Journal:  Naturwissenschaften       Date:  1981-05

6.  Phase I trial of weekly scheduling and pharmacokinetics of titanocene dichloride in patients with advanced cancer.

Authors:  C V Christodoulou; D R Ferry; D W Fyfe; A Young; J Doran; T M Sheehan; A Eliopoulos; K Hale; J Baumgart; G Sass; D J Kerr
Journal:  J Clin Oncol       Date:  1998-08       Impact factor: 44.544

7.  Study of titanocene-DNA and molybdenocene-DNA interactions by inductively coupled plasma-atomic emission spectroscopy.

Authors:  José L Vera; Félix R Román; Enrique Meléndez
Journal:  Anal Bioanal Chem       Date:  2004-04-23       Impact factor: 4.142

8.  Tumor inhibition by metallocenes: ultrastructural localization of titanium and vanadium in treated tumor cells by electron energy loss spectroscopy.

Authors:  P Köpf-Maier; D Krahl
Journal:  Chem Biol Interact       Date:  1983-06       Impact factor: 5.192

9.  Hard X-ray microprobe studies of chromium(VI)-treated V79 Chinese hamster lung cells: intracellular mapping of the biotransformation products of a chromium carcinogen.

Authors:  Carolyn T Dillon; Peter A Lay; Brendan J Kennedy; Anton P J Stampfl; Zhonghou Cai; Peter Ilinski; William Rodrigues; Daniel G Legnini; Barry Lai; Jörg Maser
Journal:  J Biol Inorg Chem       Date:  2002-02-26       Impact factor: 3.358

10.  An improved colorimetric assay for interleukin 2.

Authors:  H Tada; O Shiho; K Kuroshima; M Koyama; K Tsukamoto
Journal:  J Immunol Methods       Date:  1986-11-06       Impact factor: 2.303

View more
  12 in total

1.  Synchrotron radiation induced X-ray emission studies of the antioxidant mechanism of the organoselenium drug ebselen.

Authors:  Jade B Aitken; Peter A Lay; T T Hong Duong; Roshanak Aran; Paul K Witting; Hugh H Harris; Barry Lai; Stefan Vogt; Gregory I Giles
Journal:  J Biol Inorg Chem       Date:  2012-02-11       Impact factor: 3.358

Review 2.  In situ imaging of metals in cells and tissues.

Authors:  Reagan McRae; Pritha Bagchi; S Sumalekshmy; Christoph J Fahrni
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

3.  Specific Interactions of Antitumor Metallocenes with Deoxydinucleoside Monophosphates.

Authors:  Rahel P Eberle; Yvonne Hari; Stefan Schürch
Journal:  J Am Soc Mass Spectrom       Date:  2017-05-12       Impact factor: 3.109

4.  Bioorganometallic Chemistry of Molybdenocene Dichloride and Its Derivatives.

Authors:  Enrique Meléndez
Journal:  J Organomet Chem       Date:  2012-02-06       Impact factor: 2.369

5.  Electronic Structure of the d Bent-metallocene Cp(2)VCl(2): A Photoelectron and Density Functional Study.

Authors:  Matthew A Cranswick; Nadine E Gruhn; John H Enemark; Dennis L Lichtenberger
Journal:  J Organomet Chem       Date:  2008-04-15       Impact factor: 2.369

6.  In Vitro Characterization of a Threonine-Ligated Molybdenyl-Sulfide Cluster as a Putative Cyanide Poisoning Antidote; Intracellular Distribution, Effects on Organic Osmolyte Homeostasis, and Induction of Cell Death.

Authors:  Johanna M Gretarsdottir; Ian H Lambert; Stefan Sturup; Sigridur G Suman
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-09

7.  Exploring titanium(IV) chemical proximity to iron(III) to elucidate a function for Ti(IV) in the human body.

Authors:  Manoj Saxena; Sergio A Loza-Rosas; Kavita Gaur; Shweta Sharma; Sofia C Pérez Otero; Arthur D Tinoco
Journal:  Coord Chem Rev       Date:  2018-03-20       Impact factor: 22.315

8.  X-ray fluorescence imaging of single human cancer cells reveals that the N-heterocyclic ligands of iodinated analogues of ruthenium anticancer drugs remain coordinated after cellular uptake.

Authors:  Sumy Antony; Jade B Aitken; Stefan Vogt; Barry Lai; Tracey Brown; Leone Spiccia; Hugh H Harris
Journal:  J Biol Inorg Chem       Date:  2013-08-14       Impact factor: 3.358

Review 9.  Organometallic anticancer compounds.

Authors:  Gilles Gasser; Ingo Ott; Nils Metzler-Nolte
Journal:  J Med Chem       Date:  2010-11-15       Impact factor: 7.446

10.  On the discovery, biological effects, and use of Cisplatin and metallocenes in anticancer chemotherapy.

Authors:  Santiago Gómez-Ruiz; Danijela Maksimović-Ivanić; Sanja Mijatović; Goran N Kaluđerović
Journal:  Bioinorg Chem Appl       Date:  2012-07-12       Impact factor: 7.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.